Who are Profound Medical's investors?

Profound Medical's investors include CTI Life Sciences Fund L.P., FACIT (Fight Against Cancer Innovation Trust), Genesys Capital.

How much funding has Profound Medical raised?

Profound Medical has disclosed $877.5K raised across 1 round.

Where is Profound Medical headquartered?

Profound Medical is headquartered in Mississauga.

Profound Medical

NASDAQ: PROF

Mississauga · Founded 2015 · 182 employees on LinkedIn · 3 known investors

Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. The company's TULSA-PRO therapeutic system enables precise ablation of diseased prostate tissue in a commercial-stage medical technology setting.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Arun MenawatinCEO

Rashed DewaninChief Financial Officer2015–2026

Mathieu BurtnykinChief Operating Officer

Board

Jean-Francois PariseauBoard director

Damian LambBoard directorCo-Founder, Managing Partner at Genesys Capital

William CurranBoard director

Samira SakhiaBoard director

Kenneth GalbraithBoard director

Investors · 3

CTI Life Sciences Fund L.P.Montréal

FACIT (Fight Against Cancer Innovation Trust)Toronto · $1.1M

Genesys CapitalToronto · $730K – $3.6M

Reported raises · per SEC filings

Form D private placements

$877.5K disclosed across 1 round · 2017

▶$877.5KraisedOct 2017 · 16 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jean-Francois PariseauDirector
Damian LambDirector
Arun MenawatExecutive Officer, Director
William CurranDirector
Samira SakhiaDirector
Kenneth GalbraithDirector
Rashed DewanExecutive Officer

Offering amount: $877.5K
Amount sold: $877.5K
Sales commissions: $52.6K
Placement agents: CIBC World Markets Corp.
First sale: Sep 2017
Incorporated: Corporation, Ontario, Canada, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Profound Medical to Participate in BIG10 Conference | PROF Stock Newsstocktitan.net · Sep 2026

Profound Medical (TSX:PRN) Stock Rises 4.35% as TULSA Growth, Reimbursement and New MRI Software Drive Investor Attentionkalkine.ca · Aug 2026

Earnings call transcript: Profound Medical Q2 2026 revenue rises, stock slips 3.5% By Investing.cominvesting.com · Aug 2026

Frequently asked questions

What does Profound Medical do?: Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. The company's TULSA-PRO therapeutic system enables precise ablation of diseased prostate tissue in a commercial-stage medical technology setting.
Who are Profound Medical's investors?: Profound Medical's investors include CTI Life Sciences Fund L.P., FACIT (Fight Against Cancer Innovation Trust), Genesys Capital.
How much funding has Profound Medical raised?: Profound Medical has disclosed $877.5K raised across 1 round.
Where is Profound Medical headquartered?: Profound Medical is headquartered in Mississauga.